Elevance Health, Inc. — Director's Dealing 2017

Mar 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anthem, Inc. (ANTM)
CIK: 0001156039
Period of Report: 2017-03-01

Reporting Person: Gallina John E (EVP & Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-01	Common Stock	F	165	$166.97	Disposed	18963	Direct
2017-03-01	Common Stock	A	4867	—	Acquired	23830	Direct
2017-03-02	Common Stock	F	129	$165.97	Disposed	23701	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-01	Employee Stock Option (Right to Buy)	$166.97	A	19908	Acquired	2027-03-01	Common Stock (19908)	Direct

Footnotes

F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

F2: Represents restricted share units. Restrictions lapse as follows: 1,622 shares each on 3/1/2018 and 3/1/2019, and 1,623 on 3/1/2020.

F3: The option represents a right to purchase a total of 19,908 shares, and is exercisable in six semi-annual installments of 3,318 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date.